CompletedNot applicableNCT02127541
New Imaging Procedure for the Localisation of Insulinoma
Studying Insulinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Basel, Switzerland
- Principal Investigator
- Damian Wild, MD, PhDUniversity Hospital, Basel, Switzerland
- Intervention
- Ga -exendin PET/CT, In- exendin SPECT/CT, MRI(other)
- Enrollment
- 52 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2017
Study locations (1)
- University Hospital Basel, Basel, Switzerland
Collaborators
Insel Gruppe AG, University Hospital Bern · Desirée and Niels Yde's Foundation, Zürich, Switzerland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02127541 on ClinicalTrials.govOther trials for Insulinoma
Additional recruiting or active studies for the same condition.